Dawson, Paul A.

Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives

Arab, J. P., Karpen, S. J., Dawson, P. A., Arrese, M., & Trauner, M. (2017) · Hepatology

Liver Disease Diagnosis and TreatmentDrug Transport and Resistance Mechanisms

Cited by 634

Intestinal transport and metabolism of bile acids

Dawson, P. A., & Karpen, S. J. (2015) · Journal of Lipid Research

Drug Transport and Resistance MechanismsGut microbiota and health

Cited by 598

Single-Cell Analysis of the Liver Epithelium Reveals Dynamic Heterogeneity and an Essential Role for YAP in Homeostasis and Regeneration

Pepe-Mooney, B. J., Dill, M. T., Alemany, A., Ordovas-Montanes, J., Matsushita, Y., Rao, A., Sen, A., Miyazaki, M., Anakk, S., Dawson, P. A., et al. (2019) · Cell Stem Cell

Liver physiology and pathologyHippo pathway signaling and YAP/TAZ

Cited by 266

Inhibition of ileal bile acid uptake protects against nonalcoholic fatty liver disease in high-fat diet–fed mice

Rao, A., Kosters, A., Mells, J. E., Zhang, W., Setchell, K. D. R., Amanso, A. M., Wynn, G. M., Xu, T., Keller, B. T., Yin, H., et al. (2016) · Science Translational Medicine

Liver Disease Diagnosis and TreatmentDrug Transport and Resistance Mechanisms

Cited by 211

LY295427, a novel hypocholesterolemic agent, enhances [3H]25-hydroxycholesterol binding to liver cytosolic proteins

Bowling, N., Matter, W. F., Gadski, R. A., McClure, D. B., Schreyer, T., Dawson, P. A., & Vlahos, C. J. (1996) · Journal of Lipid Research

Cholesterol and Lipid MetabolismLipoproteins and Cardiovascular Health

Cited by 11